PB1 T35888
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
5 mg | 188714-28-5 | ¥3,160.00 | 询底价 |
100 mg | 188714-28-5 | ¥23,700.00 | 询底价 |
1 mL | 188714-28-5 | ¥3,470.00 | 询底价 |
25 mg | 188714-28-5 | ¥11,400.00 | 询底价 |
2 mg | 188714-28-5 | ¥2,120.00 | 询底价 |
50 mg | 188714-28-5 | ¥14,900.00 | 询底价 |
Product Introduction
Bioactivity
英文名: PB1
描述: PB1 is a highly-effective intracellular disulfide reducing agent with notable attributes such as excellent cell permeability, the capacity to generate a substantial intracellular concentration gradient, and remarkable stability. It serves as a borane-protected TCEP (tris(2-carboxyethyl)phosphine) analogue. PB1 demonstrates the potential to enhance the survival of retinal ganglion cells following axotomy in vitro at concentrations in the nanomolar and picomolar range. Consequently, PB1 has proven instrumental in the study of neuroprotective properties[1][2][3].
体外活性: PB1 produces a robust activation of the BDNF effector ERK1/2. PB1 promotes RGC survival[1].
体内活性: PB1 (150 μM; intraocular injection; 1 week) attenuates the loss of both RGC (retinal ganglion cells) soma and axons in experimental glaucoma[1].PB1 protects RGC soma in experimental glaucoma. PB1 single dose limits the biological activity in vivo. PB1 attenuates the loss of both RGC soma and axons in experimental glaucoma. PB1 (0.001~100 μM; 72 hours) is effective at rescuing acutely axotomized retinal ganglion cells[1][2].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 100 mg/mL (337.71 mM)
关键字: PB1 | PB 1 | PB-1
PB1 T35888信息由TargetMol中国为您提供,如您想了解更多关于PB1 T35888报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途